Primaquine

• UNSPSC Description:

  Primaquine is a potent antimalaria agent and a potent gametocytocide in falciparum malaria. Primaquine prevents relapse in vivax and ovale malaria[1][2].

• Target Antigen:

  Parasite

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Field of Research:

  Cancer; Infection

• Assay Protocol:

  https://www.medchemexpress.com/primaquine.html

• Purity:

  98.85

• Solubility:

  DMSO : 250 mg/mL (ultrasonic)

• Smiles:

  CC(NC1=C2N=CC=CC2=CC(OC)=C1)CCCN

• Molecular Weight:

  259.353

• References & Citations:

  [1]Ashley EA, et al. Primaquine: the risks and the benefits. Malar J. 2014 Nov 3;13:418. |[2]Qigui Li, et al. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections. Malar J. 2014 Apr 14:13:141. |[3]Ji-Hyang Kim, et al. Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation. Int J Mol Sci. 2021 Nov 30;22(23):12961. ACS Omega. 2024 Feb 28;9(10):11870-11882.|Advanced Therapeutics. 05 October 2021.|Ann Transl Med. 2021 Feb;9(3):194.|Cell Rep Methods. 2023 Oct 23;3(10):100599.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  Launched

• CAS Number:

  90-34-6